Global Candida Infections Drugs Supply, Demand and Key Producers, 2023-2029
The global Candida Infections Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Candida infection is a yeast infection where the skin acts as a host organism, and the infection multiplies and grows with the period. Candida albicans are the most common species of this infection. Candida normally lives on the skin and inside the body, such as the throat, gut, mouth, and vagina, without causing problems. It can cause infections if it grows out of control or enters deep into the body.
This report studies the global Candida Infections Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Candida Infections Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Candida Infections Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Candida Infections Drugs total production and demand, 2018-2029, (K Units)
Global Candida Infections Drugs total production value, 2018-2029, (USD Million)
Global Candida Infections Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Candida Infections Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Candida Infections Drugs domestic production, consumption, key domestic manufacturers and share
Global Candida Infections Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Candida Infections Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Candida Infections Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Candida Infections Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Mylan NV, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GSK plc, Novartis AG, AstraZeneca and Johnson & Johnson Private Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Candida Infections Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Candida Infections Drugs Market, By Region:
1. How big is the global Candida Infections Drugs market?
2. What is the demand of the global Candida Infections Drugs market?
3. What is the year over year growth of the global Candida Infections Drugs market?
4. What is the production and production value of the global Candida Infections Drugs market?
5. Who are the key producers in the global Candida Infections Drugs market?
6. What are the growth factors driving the market demand?
Candida infection is a yeast infection where the skin acts as a host organism, and the infection multiplies and grows with the period. Candida albicans are the most common species of this infection. Candida normally lives on the skin and inside the body, such as the throat, gut, mouth, and vagina, without causing problems. It can cause infections if it grows out of control or enters deep into the body.
This report studies the global Candida Infections Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Candida Infections Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Candida Infections Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Candida Infections Drugs total production and demand, 2018-2029, (K Units)
Global Candida Infections Drugs total production value, 2018-2029, (USD Million)
Global Candida Infections Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Candida Infections Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Candida Infections Drugs domestic production, consumption, key domestic manufacturers and share
Global Candida Infections Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Candida Infections Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Candida Infections Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Candida Infections Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Mylan NV, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GSK plc, Novartis AG, AstraZeneca and Johnson & Johnson Private Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Candida Infections Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Candida Infections Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Azole
- Nystatin
- Other
- Beriberi
- Jock Itch
- Vaginal Infection
- Other
- F. Hoffmann-La Roche Ltd
- Mylan NV
- Teva Pharmaceutical Industries Ltd
- Sanofi
- Pfizer Inc
- GSK plc
- Novartis AG
- AstraZeneca
- Johnson & Johnson Private Limited
- Sun Pharmaceutical Industries Ltd
- Merck & Co., Inc
- Bristol-Myers Squibb Company
- Lilly
- Amgen Inc
1. How big is the global Candida Infections Drugs market?
2. What is the demand of the global Candida Infections Drugs market?
3. What is the year over year growth of the global Candida Infections Drugs market?
4. What is the production and production value of the global Candida Infections Drugs market?
5. Who are the key producers in the global Candida Infections Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Candida Infections Drugs Introduction
1.2 World Candida Infections Drugs Supply & Forecast
1.2.1 World Candida Infections Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Candida Infections Drugs Production (2018-2029)
1.2.3 World Candida Infections Drugs Pricing Trends (2018-2029)
1.3 World Candida Infections Drugs Production by Region (Based on Production Site)
1.3.1 World Candida Infections Drugs Production Value by Region (2018-2029)
1.3.2 World Candida Infections Drugs Production by Region (2018-2029)
1.3.3 World Candida Infections Drugs Average Price by Region (2018-2029)
1.3.4 North America Candida Infections Drugs Production (2018-2029)
1.3.5 Europe Candida Infections Drugs Production (2018-2029)
1.3.6 China Candida Infections Drugs Production (2018-2029)
1.3.7 Japan Candida Infections Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Candida Infections Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Candida Infections Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Candida Infections Drugs Demand (2018-2029)
2.2 World Candida Infections Drugs Consumption by Region
2.2.1 World Candida Infections Drugs Consumption by Region (2018-2023)
2.2.2 World Candida Infections Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Candida Infections Drugs Consumption (2018-2029)
2.4 China Candida Infections Drugs Consumption (2018-2029)
2.5 Europe Candida Infections Drugs Consumption (2018-2029)
2.6 Japan Candida Infections Drugs Consumption (2018-2029)
2.7 South Korea Candida Infections Drugs Consumption (2018-2029)
2.8 ASEAN Candida Infections Drugs Consumption (2018-2029)
2.9 India Candida Infections Drugs Consumption (2018-2029)
3 WORLD CANDIDA INFECTIONS DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Candida Infections Drugs Production Value by Manufacturer (2018-2023)
3.2 World Candida Infections Drugs Production by Manufacturer (2018-2023)
3.3 World Candida Infections Drugs Average Price by Manufacturer (2018-2023)
3.4 Candida Infections Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Candida Infections Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Candida Infections Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Candida Infections Drugs in 2022
3.6 Candida Infections Drugs Market: Overall Company Footprint Analysis
3.6.1 Candida Infections Drugs Market: Region Footprint
3.6.2 Candida Infections Drugs Market: Company Product Type Footprint
3.6.3 Candida Infections Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Candida Infections Drugs Production Value Comparison
4.1.1 United States VS China: Candida Infections Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Candida Infections Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Candida Infections Drugs Production Comparison
4.2.1 United States VS China: Candida Infections Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Candida Infections Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Candida Infections Drugs Consumption Comparison
4.3.1 United States VS China: Candida Infections Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Candida Infections Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Candida Infections Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Candida Infections Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Candida Infections Drugs Production (2018-2023)
4.5 China Based Candida Infections Drugs Manufacturers and Market Share
4.5.1 China Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Candida Infections Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Candida Infections Drugs Production (2018-2023)
4.6 Rest of World Based Candida Infections Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Candida Infections Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Candida Infections Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Candida Infections Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Azole
5.2.2 Nystatin
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Candida Infections Drugs Production by Type (2018-2029)
5.3.2 World Candida Infections Drugs Production Value by Type (2018-2029)
5.3.3 World Candida Infections Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Candida Infections Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Beriberi
6.2.2 Jock Itch
6.2.3 Vaginal Infection
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Candida Infections Drugs Production by Application (2018-2029)
6.3.2 World Candida Infections Drugs Production Value by Application (2018-2029)
6.3.3 World Candida Infections Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Details
7.1.2 F. Hoffmann-La Roche Ltd Major Business
7.1.3 F. Hoffmann-La Roche Ltd Candida Infections Drugs Product and Services
7.1.4 F. Hoffmann-La Roche Ltd Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.1.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.2 Mylan NV
7.2.1 Mylan NV Details
7.2.2 Mylan NV Major Business
7.2.3 Mylan NV Candida Infections Drugs Product and Services
7.2.4 Mylan NV Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Mylan NV Recent Developments/Updates
7.2.6 Mylan NV Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Details
7.3.2 Teva Pharmaceutical Industries Ltd Major Business
7.3.3 Teva Pharmaceutical Industries Ltd Candida Infections Drugs Product and Services
7.3.4 Teva Pharmaceutical Industries Ltd Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Candida Infections Drugs Product and Services
7.4.4 Sanofi Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Pfizer Inc
7.5.1 Pfizer Inc Details
7.5.2 Pfizer Inc Major Business
7.5.3 Pfizer Inc Candida Infections Drugs Product and Services
7.5.4 Pfizer Inc Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Inc Recent Developments/Updates
7.5.6 Pfizer Inc Competitive Strengths & Weaknesses
7.6 GSK plc
7.6.1 GSK plc Details
7.6.2 GSK plc Major Business
7.6.3 GSK plc Candida Infections Drugs Product and Services
7.6.4 GSK plc Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GSK plc Recent Developments/Updates
7.6.6 GSK plc Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG Candida Infections Drugs Product and Services
7.7.4 Novartis AG Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Candida Infections Drugs Product and Services
7.8.4 AstraZeneca Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Johnson & Johnson Private Limited
7.9.1 Johnson & Johnson Private Limited Details
7.9.2 Johnson & Johnson Private Limited Major Business
7.9.3 Johnson & Johnson Private Limited Candida Infections Drugs Product and Services
7.9.4 Johnson & Johnson Private Limited Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Johnson & Johnson Private Limited Recent Developments/Updates
7.9.6 Johnson & Johnson Private Limited Competitive Strengths & Weaknesses
7.10 Sun Pharmaceutical Industries Ltd
7.10.1 Sun Pharmaceutical Industries Ltd Details
7.10.2 Sun Pharmaceutical Industries Ltd Major Business
7.10.3 Sun Pharmaceutical Industries Ltd Candida Infections Drugs Product and Services
7.10.4 Sun Pharmaceutical Industries Ltd Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.10.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.11 Merck & Co., Inc
7.11.1 Merck & Co., Inc Details
7.11.2 Merck & Co., Inc Major Business
7.11.3 Merck & Co., Inc Candida Infections Drugs Product and Services
7.11.4 Merck & Co., Inc Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Merck & Co., Inc Recent Developments/Updates
7.11.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.12 Bristol-Myers Squibb Company
7.12.1 Bristol-Myers Squibb Company Details
7.12.2 Bristol-Myers Squibb Company Major Business
7.12.3 Bristol-Myers Squibb Company Candida Infections Drugs Product and Services
7.12.4 Bristol-Myers Squibb Company Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.12.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.13 Lilly
7.13.1 Lilly Details
7.13.2 Lilly Major Business
7.13.3 Lilly Candida Infections Drugs Product and Services
7.13.4 Lilly Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Lilly Recent Developments/Updates
7.13.6 Lilly Competitive Strengths & Weaknesses
7.14 Amgen Inc
7.14.1 Amgen Inc Details
7.14.2 Amgen Inc Major Business
7.14.3 Amgen Inc Candida Infections Drugs Product and Services
7.14.4 Amgen Inc Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Amgen Inc Recent Developments/Updates
7.14.6 Amgen Inc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Candida Infections Drugs Industry Chain
8.2 Candida Infections Drugs Upstream Analysis
8.2.1 Candida Infections Drugs Core Raw Materials
8.2.2 Main Manufacturers of Candida Infections Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Candida Infections Drugs Production Mode
8.6 Candida Infections Drugs Procurement Model
8.7 Candida Infections Drugs Industry Sales Model and Sales Channels
8.7.1 Candida Infections Drugs Sales Model
8.7.2 Candida Infections Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Candida Infections Drugs Introduction
1.2 World Candida Infections Drugs Supply & Forecast
1.2.1 World Candida Infections Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Candida Infections Drugs Production (2018-2029)
1.2.3 World Candida Infections Drugs Pricing Trends (2018-2029)
1.3 World Candida Infections Drugs Production by Region (Based on Production Site)
1.3.1 World Candida Infections Drugs Production Value by Region (2018-2029)
1.3.2 World Candida Infections Drugs Production by Region (2018-2029)
1.3.3 World Candida Infections Drugs Average Price by Region (2018-2029)
1.3.4 North America Candida Infections Drugs Production (2018-2029)
1.3.5 Europe Candida Infections Drugs Production (2018-2029)
1.3.6 China Candida Infections Drugs Production (2018-2029)
1.3.7 Japan Candida Infections Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Candida Infections Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Candida Infections Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Candida Infections Drugs Demand (2018-2029)
2.2 World Candida Infections Drugs Consumption by Region
2.2.1 World Candida Infections Drugs Consumption by Region (2018-2023)
2.2.2 World Candida Infections Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Candida Infections Drugs Consumption (2018-2029)
2.4 China Candida Infections Drugs Consumption (2018-2029)
2.5 Europe Candida Infections Drugs Consumption (2018-2029)
2.6 Japan Candida Infections Drugs Consumption (2018-2029)
2.7 South Korea Candida Infections Drugs Consumption (2018-2029)
2.8 ASEAN Candida Infections Drugs Consumption (2018-2029)
2.9 India Candida Infections Drugs Consumption (2018-2029)
3 WORLD CANDIDA INFECTIONS DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Candida Infections Drugs Production Value by Manufacturer (2018-2023)
3.2 World Candida Infections Drugs Production by Manufacturer (2018-2023)
3.3 World Candida Infections Drugs Average Price by Manufacturer (2018-2023)
3.4 Candida Infections Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Candida Infections Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Candida Infections Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Candida Infections Drugs in 2022
3.6 Candida Infections Drugs Market: Overall Company Footprint Analysis
3.6.1 Candida Infections Drugs Market: Region Footprint
3.6.2 Candida Infections Drugs Market: Company Product Type Footprint
3.6.3 Candida Infections Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Candida Infections Drugs Production Value Comparison
4.1.1 United States VS China: Candida Infections Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Candida Infections Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Candida Infections Drugs Production Comparison
4.2.1 United States VS China: Candida Infections Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Candida Infections Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Candida Infections Drugs Consumption Comparison
4.3.1 United States VS China: Candida Infections Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Candida Infections Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Candida Infections Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Candida Infections Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Candida Infections Drugs Production (2018-2023)
4.5 China Based Candida Infections Drugs Manufacturers and Market Share
4.5.1 China Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Candida Infections Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Candida Infections Drugs Production (2018-2023)
4.6 Rest of World Based Candida Infections Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Candida Infections Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Candida Infections Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Candida Infections Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Azole
5.2.2 Nystatin
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Candida Infections Drugs Production by Type (2018-2029)
5.3.2 World Candida Infections Drugs Production Value by Type (2018-2029)
5.3.3 World Candida Infections Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Candida Infections Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Beriberi
6.2.2 Jock Itch
6.2.3 Vaginal Infection
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Candida Infections Drugs Production by Application (2018-2029)
6.3.2 World Candida Infections Drugs Production Value by Application (2018-2029)
6.3.3 World Candida Infections Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Details
7.1.2 F. Hoffmann-La Roche Ltd Major Business
7.1.3 F. Hoffmann-La Roche Ltd Candida Infections Drugs Product and Services
7.1.4 F. Hoffmann-La Roche Ltd Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.1.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.2 Mylan NV
7.2.1 Mylan NV Details
7.2.2 Mylan NV Major Business
7.2.3 Mylan NV Candida Infections Drugs Product and Services
7.2.4 Mylan NV Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Mylan NV Recent Developments/Updates
7.2.6 Mylan NV Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Details
7.3.2 Teva Pharmaceutical Industries Ltd Major Business
7.3.3 Teva Pharmaceutical Industries Ltd Candida Infections Drugs Product and Services
7.3.4 Teva Pharmaceutical Industries Ltd Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Candida Infections Drugs Product and Services
7.4.4 Sanofi Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Pfizer Inc
7.5.1 Pfizer Inc Details
7.5.2 Pfizer Inc Major Business
7.5.3 Pfizer Inc Candida Infections Drugs Product and Services
7.5.4 Pfizer Inc Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Inc Recent Developments/Updates
7.5.6 Pfizer Inc Competitive Strengths & Weaknesses
7.6 GSK plc
7.6.1 GSK plc Details
7.6.2 GSK plc Major Business
7.6.3 GSK plc Candida Infections Drugs Product and Services
7.6.4 GSK plc Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GSK plc Recent Developments/Updates
7.6.6 GSK plc Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG Candida Infections Drugs Product and Services
7.7.4 Novartis AG Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Candida Infections Drugs Product and Services
7.8.4 AstraZeneca Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Johnson & Johnson Private Limited
7.9.1 Johnson & Johnson Private Limited Details
7.9.2 Johnson & Johnson Private Limited Major Business
7.9.3 Johnson & Johnson Private Limited Candida Infections Drugs Product and Services
7.9.4 Johnson & Johnson Private Limited Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Johnson & Johnson Private Limited Recent Developments/Updates
7.9.6 Johnson & Johnson Private Limited Competitive Strengths & Weaknesses
7.10 Sun Pharmaceutical Industries Ltd
7.10.1 Sun Pharmaceutical Industries Ltd Details
7.10.2 Sun Pharmaceutical Industries Ltd Major Business
7.10.3 Sun Pharmaceutical Industries Ltd Candida Infections Drugs Product and Services
7.10.4 Sun Pharmaceutical Industries Ltd Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.10.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.11 Merck & Co., Inc
7.11.1 Merck & Co., Inc Details
7.11.2 Merck & Co., Inc Major Business
7.11.3 Merck & Co., Inc Candida Infections Drugs Product and Services
7.11.4 Merck & Co., Inc Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Merck & Co., Inc Recent Developments/Updates
7.11.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.12 Bristol-Myers Squibb Company
7.12.1 Bristol-Myers Squibb Company Details
7.12.2 Bristol-Myers Squibb Company Major Business
7.12.3 Bristol-Myers Squibb Company Candida Infections Drugs Product and Services
7.12.4 Bristol-Myers Squibb Company Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.12.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.13 Lilly
7.13.1 Lilly Details
7.13.2 Lilly Major Business
7.13.3 Lilly Candida Infections Drugs Product and Services
7.13.4 Lilly Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Lilly Recent Developments/Updates
7.13.6 Lilly Competitive Strengths & Weaknesses
7.14 Amgen Inc
7.14.1 Amgen Inc Details
7.14.2 Amgen Inc Major Business
7.14.3 Amgen Inc Candida Infections Drugs Product and Services
7.14.4 Amgen Inc Candida Infections Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Amgen Inc Recent Developments/Updates
7.14.6 Amgen Inc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Candida Infections Drugs Industry Chain
8.2 Candida Infections Drugs Upstream Analysis
8.2.1 Candida Infections Drugs Core Raw Materials
8.2.2 Main Manufacturers of Candida Infections Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Candida Infections Drugs Production Mode
8.6 Candida Infections Drugs Procurement Model
8.7 Candida Infections Drugs Industry Sales Model and Sales Channels
8.7.1 Candida Infections Drugs Sales Model
8.7.2 Candida Infections Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Candida Infections Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Candida Infections Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Candida Infections Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Candida Infections Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Candida Infections Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Candida Infections Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Candida Infections Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Candida Infections Drugs Production Market Share by Region (2018-2023)
Table 9. World Candida Infections Drugs Production Market Share by Region (2024-2029)
Table 10. World Candida Infections Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Candida Infections Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Candida Infections Drugs Major Market Trends
Table 13. World Candida Infections Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Candida Infections Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Candida Infections Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Candida Infections Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Candida Infections Drugs Producers in 2022
Table 18. World Candida Infections Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Candida Infections Drugs Producers in 2022
Table 20. World Candida Infections Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Candida Infections Drugs Company Evaluation Quadrant
Table 22. World Candida Infections Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Candida Infections Drugs Production Site of Key Manufacturer
Table 24. Candida Infections Drugs Market: Company Product Type Footprint
Table 25. Candida Infections Drugs Market: Company Product Application Footprint
Table 26. Candida Infections Drugs Competitive Factors
Table 27. Candida Infections Drugs New Entrant and Capacity Expansion Plans
Table 28. Candida Infections Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Candida Infections Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Candida Infections Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Candida Infections Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Candida Infections Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Candida Infections Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Candida Infections Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Candida Infections Drugs Production Market Share (2018-2023)
Table 37. China Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Candida Infections Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Candida Infections Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Candida Infections Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Candida Infections Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Candida Infections Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Candida Infections Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Candida Infections Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Candida Infections Drugs Production Market Share (2018-2023)
Table 47. World Candida Infections Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Candida Infections Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Candida Infections Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Candida Infections Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Candida Infections Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Candida Infections Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Candida Infections Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Candida Infections Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Candida Infections Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Candida Infections Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Candida Infections Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Candida Infections Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Candida Infections Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Candida Infections Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 62. F. Hoffmann-La Roche Ltd Major Business
Table 63. F. Hoffmann-La Roche Ltd Candida Infections Drugs Product and Services
Table 64. F. Hoffmann-La Roche Ltd Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 66. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 67. Mylan NV Basic Information, Manufacturing Base and Competitors
Table 68. Mylan NV Major Business
Table 69. Mylan NV Candida Infections Drugs Product and Services
Table 70. Mylan NV Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Mylan NV Recent Developments/Updates
Table 72. Mylan NV Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Industries Ltd Major Business
Table 75. Teva Pharmaceutical Industries Ltd Candida Infections Drugs Product and Services
Table 76. Teva Pharmaceutical Industries Ltd Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Candida Infections Drugs Product and Services
Table 82. Sanofi Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Inc Major Business
Table 87. Pfizer Inc Candida Infections Drugs Product and Services
Table 88. Pfizer Inc Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Pfizer Inc Competitive Strengths & Weaknesses
Table 91. GSK plc Basic Information, Manufacturing Base and Competitors
Table 92. GSK plc Major Business
Table 93. GSK plc Candida Infections Drugs Product and Services
Table 94. GSK plc Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GSK plc Recent Developments/Updates
Table 96. GSK plc Competitive Strengths & Weaknesses
Table 97. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 98. Novartis AG Major Business
Table 99. Novartis AG Candida Infections Drugs Product and Services
Table 100. Novartis AG Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Novartis AG Recent Developments/Updates
Table 102. Novartis AG Competitive Strengths & Weaknesses
Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 104. AstraZeneca Major Business
Table 105. AstraZeneca Candida Infections Drugs Product and Services
Table 106. AstraZeneca Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AstraZeneca Recent Developments/Updates
Table 108. AstraZeneca Competitive Strengths & Weaknesses
Table 109. Johnson & Johnson Private Limited Basic Information, Manufacturing Base and Competitors
Table 110. Johnson & Johnson Private Limited Major Business
Table 111. Johnson & Johnson Private Limited Candida Infections Drugs Product and Services
Table 112. Johnson & Johnson Private Limited Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Johnson & Johnson Private Limited Recent Developments/Updates
Table 114. Johnson & Johnson Private Limited Competitive Strengths & Weaknesses
Table 115. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Sun Pharmaceutical Industries Ltd Major Business
Table 117. Sun Pharmaceutical Industries Ltd Candida Infections Drugs Product and Services
Table 118. Sun Pharmaceutical Industries Ltd Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 121. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 122. Merck & Co., Inc Major Business
Table 123. Merck & Co., Inc Candida Infections Drugs Product and Services
Table 124. Merck & Co., Inc Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Merck & Co., Inc Recent Developments/Updates
Table 126. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 127. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 128. Bristol-Myers Squibb Company Major Business
Table 129. Bristol-Myers Squibb Company Candida Infections Drugs Product and Services
Table 130. Bristol-Myers Squibb Company Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Bristol-Myers Squibb Company Recent Developments/Updates
Table 132. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 133. Lilly Basic Information, Manufacturing Base and Competitors
Table 134. Lilly Major Business
Table 135. Lilly Candida Infections Drugs Product and Services
Table 136. Lilly Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Lilly Recent Developments/Updates
Table 138. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 139. Amgen Inc Major Business
Table 140. Amgen Inc Candida Infections Drugs Product and Services
Table 141. Amgen Inc Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Candida Infections Drugs Upstream (Raw Materials)
Table 143. Candida Infections Drugs Typical Customers
Table 144. Candida Infections Drugs Typical Distributors
Table 1. World Candida Infections Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Candida Infections Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Candida Infections Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Candida Infections Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Candida Infections Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Candida Infections Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Candida Infections Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Candida Infections Drugs Production Market Share by Region (2018-2023)
Table 9. World Candida Infections Drugs Production Market Share by Region (2024-2029)
Table 10. World Candida Infections Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Candida Infections Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Candida Infections Drugs Major Market Trends
Table 13. World Candida Infections Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Candida Infections Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Candida Infections Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Candida Infections Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Candida Infections Drugs Producers in 2022
Table 18. World Candida Infections Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Candida Infections Drugs Producers in 2022
Table 20. World Candida Infections Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Candida Infections Drugs Company Evaluation Quadrant
Table 22. World Candida Infections Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Candida Infections Drugs Production Site of Key Manufacturer
Table 24. Candida Infections Drugs Market: Company Product Type Footprint
Table 25. Candida Infections Drugs Market: Company Product Application Footprint
Table 26. Candida Infections Drugs Competitive Factors
Table 27. Candida Infections Drugs New Entrant and Capacity Expansion Plans
Table 28. Candida Infections Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Candida Infections Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Candida Infections Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Candida Infections Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Candida Infections Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Candida Infections Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Candida Infections Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Candida Infections Drugs Production Market Share (2018-2023)
Table 37. China Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Candida Infections Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Candida Infections Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Candida Infections Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Candida Infections Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Candida Infections Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Candida Infections Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Candida Infections Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Candida Infections Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Candida Infections Drugs Production Market Share (2018-2023)
Table 47. World Candida Infections Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Candida Infections Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Candida Infections Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Candida Infections Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Candida Infections Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Candida Infections Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Candida Infections Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Candida Infections Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Candida Infections Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Candida Infections Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Candida Infections Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Candida Infections Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Candida Infections Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Candida Infections Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 62. F. Hoffmann-La Roche Ltd Major Business
Table 63. F. Hoffmann-La Roche Ltd Candida Infections Drugs Product and Services
Table 64. F. Hoffmann-La Roche Ltd Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 66. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 67. Mylan NV Basic Information, Manufacturing Base and Competitors
Table 68. Mylan NV Major Business
Table 69. Mylan NV Candida Infections Drugs Product and Services
Table 70. Mylan NV Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Mylan NV Recent Developments/Updates
Table 72. Mylan NV Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Industries Ltd Major Business
Table 75. Teva Pharmaceutical Industries Ltd Candida Infections Drugs Product and Services
Table 76. Teva Pharmaceutical Industries Ltd Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Candida Infections Drugs Product and Services
Table 82. Sanofi Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Inc Major Business
Table 87. Pfizer Inc Candida Infections Drugs Product and Services
Table 88. Pfizer Inc Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Pfizer Inc Competitive Strengths & Weaknesses
Table 91. GSK plc Basic Information, Manufacturing Base and Competitors
Table 92. GSK plc Major Business
Table 93. GSK plc Candida Infections Drugs Product and Services
Table 94. GSK plc Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GSK plc Recent Developments/Updates
Table 96. GSK plc Competitive Strengths & Weaknesses
Table 97. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 98. Novartis AG Major Business
Table 99. Novartis AG Candida Infections Drugs Product and Services
Table 100. Novartis AG Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Novartis AG Recent Developments/Updates
Table 102. Novartis AG Competitive Strengths & Weaknesses
Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 104. AstraZeneca Major Business
Table 105. AstraZeneca Candida Infections Drugs Product and Services
Table 106. AstraZeneca Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AstraZeneca Recent Developments/Updates
Table 108. AstraZeneca Competitive Strengths & Weaknesses
Table 109. Johnson & Johnson Private Limited Basic Information, Manufacturing Base and Competitors
Table 110. Johnson & Johnson Private Limited Major Business
Table 111. Johnson & Johnson Private Limited Candida Infections Drugs Product and Services
Table 112. Johnson & Johnson Private Limited Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Johnson & Johnson Private Limited Recent Developments/Updates
Table 114. Johnson & Johnson Private Limited Competitive Strengths & Weaknesses
Table 115. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Sun Pharmaceutical Industries Ltd Major Business
Table 117. Sun Pharmaceutical Industries Ltd Candida Infections Drugs Product and Services
Table 118. Sun Pharmaceutical Industries Ltd Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 121. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 122. Merck & Co., Inc Major Business
Table 123. Merck & Co., Inc Candida Infections Drugs Product and Services
Table 124. Merck & Co., Inc Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Merck & Co., Inc Recent Developments/Updates
Table 126. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 127. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 128. Bristol-Myers Squibb Company Major Business
Table 129. Bristol-Myers Squibb Company Candida Infections Drugs Product and Services
Table 130. Bristol-Myers Squibb Company Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Bristol-Myers Squibb Company Recent Developments/Updates
Table 132. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 133. Lilly Basic Information, Manufacturing Base and Competitors
Table 134. Lilly Major Business
Table 135. Lilly Candida Infections Drugs Product and Services
Table 136. Lilly Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Lilly Recent Developments/Updates
Table 138. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 139. Amgen Inc Major Business
Table 140. Amgen Inc Candida Infections Drugs Product and Services
Table 141. Amgen Inc Candida Infections Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Candida Infections Drugs Upstream (Raw Materials)
Table 143. Candida Infections Drugs Typical Customers
Table 144. Candida Infections Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Candida Infections Drugs Picture
Figure 2. World Candida Infections Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Candida Infections Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 5. World Candida Infections Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Candida Infections Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Candida Infections Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 10. China Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 12. Candida Infections Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Candida Infections Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Candida Infections Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Candida Infections Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Candida Infections Drugs Markets in 2022
Figure 26. United States VS China: Candida Infections Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Candida Infections Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Candida Infections Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Candida Infections Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Candida Infections Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Candida Infections Drugs Production Market Share 2022
Figure 32. World Candida Infections Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Candida Infections Drugs Production Value Market Share by Type in 2022
Figure 34. Azole
Figure 35. Nystatin
Figure 36. Other
Figure 37. World Candida Infections Drugs Production Market Share by Type (2018-2029)
Figure 38. World Candida Infections Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World Candida Infections Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Candida Infections Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Candida Infections Drugs Production Value Market Share by Application in 2022
Figure 42. Beriberi
Figure 43. Jock Itch
Figure 44. Vaginal Infection
Figure 45. Other
Figure 46. World Candida Infections Drugs Production Market Share by Application (2018-2029)
Figure 47. World Candida Infections Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World Candida Infections Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Candida Infections Drugs Industry Chain
Figure 50. Candida Infections Drugs Procurement Model
Figure 51. Candida Infections Drugs Sales Model
Figure 52. Candida Infections Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Candida Infections Drugs Picture
Figure 2. World Candida Infections Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Candida Infections Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 5. World Candida Infections Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Candida Infections Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Candida Infections Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 10. China Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Candida Infections Drugs Production (2018-2029) & (K Units)
Figure 12. Candida Infections Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Candida Infections Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Candida Infections Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Candida Infections Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Candida Infections Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Candida Infections Drugs Markets in 2022
Figure 26. United States VS China: Candida Infections Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Candida Infections Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Candida Infections Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Candida Infections Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Candida Infections Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Candida Infections Drugs Production Market Share 2022
Figure 32. World Candida Infections Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Candida Infections Drugs Production Value Market Share by Type in 2022
Figure 34. Azole
Figure 35. Nystatin
Figure 36. Other
Figure 37. World Candida Infections Drugs Production Market Share by Type (2018-2029)
Figure 38. World Candida Infections Drugs Production Value Market Share by Type (2018-2029)
Figure 39. World Candida Infections Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Candida Infections Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Candida Infections Drugs Production Value Market Share by Application in 2022
Figure 42. Beriberi
Figure 43. Jock Itch
Figure 44. Vaginal Infection
Figure 45. Other
Figure 46. World Candida Infections Drugs Production Market Share by Application (2018-2029)
Figure 47. World Candida Infections Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World Candida Infections Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Candida Infections Drugs Industry Chain
Figure 50. Candida Infections Drugs Procurement Model
Figure 51. Candida Infections Drugs Sales Model
Figure 52. Candida Infections Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
